Compare Heron Therapeutics Inc (HRTX) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Oxford Lane Capital Corp — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Oxford Lane Capital Corp trades at $8.82 (market cap $866.15M). The key difference: Oxford Lane Capital Corp is far larger — about 9.5× Heron Therapeutics Inc's market cap, and Oxford Lane Capital Corp pays a 27.06% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | OXLC | |
|---|---|---|
Market Cap | $91.46M | $866.15M |
Sector | Health | Financials |
52-Week High | $1.96 | $19.90 |
52-Week Low | $0.39 | $8.15 |
Enterprise Value | $189.36M | — |
Dividend Yield | — | 27.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
